Institutional investors hold a majority ownership of ABT through the 75.37% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended September 2016, these large investors purchased a net $29.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NNIP ADVISORS BV Bought 484.8 Thousand shares of Abbott Laboratories